262 related articles for article (PubMed ID: 20538040)
1. Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.
Yao J; Hamilton RT; Cadenas E; Brinton RD
Biochim Biophys Acta; 2010 Oct; 1800(10):1121-6. PubMed ID: 20538040
[TBL] [Abstract][Full Text] [Related]
2. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
[TBL] [Abstract][Full Text] [Related]
5. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
6. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's.
Ding F; Yao J; Zhao L; Mao Z; Chen S; Brinton RD
PLoS One; 2013; 8(3):e59825. PubMed ID: 23555795
[TBL] [Abstract][Full Text] [Related]
7. Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.
Yao J; Irwin R; Chen S; Hamilton R; Cadenas E; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1507-21. PubMed ID: 21514693
[TBL] [Abstract][Full Text] [Related]
8. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Osorio RS; Connaughty C; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Swerdlow RH; Brinton RD
PLoS One; 2017; 12(10):e0185926. PubMed ID: 29016679
[TBL] [Abstract][Full Text] [Related]
9. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
Wang T; Yao J; Chen S; Mao Z; Brinton RD
Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
[TBL] [Abstract][Full Text] [Related]
11. Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model.
Niño SA; Morales-Martínez A; Chi-Ahumada E; Carrizales L; Salgado-Delgado R; Pérez-Severiano F; Díaz-Cintra S; Jiménez-Capdeville ME; Zarazúa S
ACS Chem Neurosci; 2019 Jan; 10(1):323-336. PubMed ID: 30141907
[TBL] [Abstract][Full Text] [Related]
12. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
Pawlosky RJ; Kemper MF; Kashiwaya Y; King MT; Mattson MP; Veech RL
J Neurochem; 2017 Apr; 141(2):195-207. PubMed ID: 28099989
[TBL] [Abstract][Full Text] [Related]
13. Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.
Strazielle C; Jazi R; Verdier Y; Qian S; Lalonde R
Neurochem Int; 2009 Dec; 55(8):806-14. PubMed ID: 19682525
[TBL] [Abstract][Full Text] [Related]
14. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession.
Liu D; Pitta M; Jiang H; Lee JH; Zhang G; Chen X; Kawamoto EM; Mattson MP
Neurobiol Aging; 2013 Jun; 34(6):1564-80. PubMed ID: 23273573
[TBL] [Abstract][Full Text] [Related]
17. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging.
Manczak M; Jung Y; Park BS; Partovi D; Reddy PH
J Neurochem; 2005 Feb; 92(3):494-504. PubMed ID: 15659220
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
[TBL] [Abstract][Full Text] [Related]
19. Estrogen: a master regulator of bioenergetic systems in the brain and body.
Rettberg JR; Yao J; Brinton RD
Front Neuroendocrinol; 2014 Jan; 35(1):8-30. PubMed ID: 23994581
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.
Yao J; Brinton RD
Curr Pharm Des; 2011; 17(31):3474-9. PubMed ID: 21902662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
